Decision aid reduces conflict in breast cancer treatment

July 19, 2013
Decision aid reduces conflict in breast cancer treatment
Chinese women considering surgery for breast cancer have less decisional conflict and subsequent regret if they receive an educational take-home booklet to involve them in decision making, according to a study published online July 8 in the Journal of Clinical Oncology.

(HealthDay)—Chinese women considering surgery for breast cancer have less decisional conflict and subsequent regret if they receive an educational take-home booklet to involve them in decision making, according to a study published online July 8 in the Journal of Clinical Oncology.

Noting that breast cancer decision aid studies have been done in Western women for primary surgery, Wendy W.T. Lam, Ph.D., from the University of Hong Kong, and colleagues randomly assigned 276 Chinese women considering surgery for early-stage to a take-home booklet (decision aid) or the standard information booklet (control) after the initial consultation.

Based on interview-based questionnaires, the researchers found that decisional conflict scores were significantly lower for the decision-aid group one week after consultation. The decision-aid group also had significantly lower decision regret scores four and 10 months after surgery and significantly lower depression scores 10 months after surgery.

"Use of this decision aid was associated with reductions in decisional conflict, decision regret, and depression over time without increasing among Chinese women," Lam and colleagues write.

Explore further: Patient decision aid beneficial in papillary thyroid cancer

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Patient decision aid beneficial in papillary thyroid cancer

July 6, 2012
(HealthDay) -- Patients with early-stage papillary thyroid cancer (PTC) may benefit from the use of a patient-directed computerized decision aid (DA) to provide medical knowledge and resolve decisional conflicts regarding ...

Young breast cancer patients often opt for mastectomy

May 30, 2013
A new study of young women with breast cancer has found that most chose to have a mastectomy rather than a surgical procedure that would conserve the breast, researchers will report at the 49th Annual Meeting of the American ...

Pre-test genetic counseling increases cancer knowledge for BRCA patients

August 15, 2012
(Medical Xpress) -- Researchers at Moffitt Cancer Center have found that when breast cancer patients are offered pre-test genetic counseling before definitive breast cancer surgery, patients exhibited decreases in distress. ...

New decision aid for treatment of herniated disc beneficial

August 23, 2012
(HealthDay)—A new patient decision instrument meets the criteria of acceptability, reliability, and validity, and improves the quality of patient decision-making for treatment of a herniated disc, according to a study published ...

Many suffer chronic pain after breast cancer surgery, study finds

January 22, 2013
(HealthDay)—About one-quarter of women who've had breast cancer surgery have significant and persistent breast pain six months after the procedure, a new study finds.

Pre-op breast pain in about 28 percent of breast cancer patients

June 15, 2012
(HealthDay) -- More than a quarter of women about to undergo breast cancer surgery experience breast pain, with genetic polymorphisms in inflammatory cytokines correlating with pain, according to a study published in the ...

Recommended for you

'Hijacker' drives cancer in some patients with high-risk neuroblastoma

January 23, 2018
Researchers have identified mechanisms that drive about 10 percent of high-risk neuroblastoma cases and have used a new approach to show how the cancer genome "hijacks" DNA that regulates other genes. The resulting insights ...

Enzyme inhibitor combined with chemotherapy delays glioblastoma growth

January 23, 2018
In animal experiments, a human-derived glioblastoma significantly regressed when treated with the combination of an experimental enzyme inhibitor and the standard glioblastoma chemotherapy drug, temozolomide.

Scientists block the siren call of two aggressive cancers

January 23, 2018
Aggressive cancers like glioblastoma and metastatic breast cancer have in common a siren call that beckons the bone marrow to send along whatever the tumors need to survive and thrive.

Researchers identify a protein that keeps metastatic breast cancer cells dormant

January 23, 2018
A study headed by ICREA researcher Roger Gomis at the Institute for Research in Biomedicine (IRB Barcelona) has identified the genes involved in the latent asymptomatic state of breast cancer metastases. The work sheds light ...

Workouts may boost life span after breast cancer

January 22, 2018
(HealthDay)—Longer survival after breast cancer may be as simple as staying fit, new research shows.

Boosting cancer therapy with cross-dressed immune cells

January 22, 2018
Researchers at EPFL have created artificial molecules that can help the immune system to recognize and attack cancer tumors. The study is published in Nature Methods.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.